Spanish women are having fewer and fewer children, and yet the country has become the egg donation capital of Europe. In this episode of The Conversation Weekly podcast, we find out about the experiences of women who decide to donate their eggs, and whether there are enough protections in place to prevent them from being exploited.
Over the past 20 years, the number of egg donation cycles in Europe has been steadily increasing, reaching more than 80,000 in 2018. Around half of these take place in Spain, which has positioned itself as Europe’s go-to destination for people seeking donated eggs.
According to Anna Molas, a research fellow in anthropology at the Autonomous University of Barcelona, Spain currently has “the most flexible assisted reproductive law across Europe”. There is no age-limit for women who want to use private clinics, and no access restrictions in terms of marital status or sexual orientation.
An egg donation industry has developed in Spain to feed the demand for donor eggs, much of which is driven by women over the age of 40 who need help to have a baby. Adverts on social media encouraging women to donate their eggs are common. Around 15,000 women go through egg donation cycles every year in Spain.
When Molas interviewed women in Spain about their experiences, she found that the main reason they chose to donate was economic. A donor typically receives €1,100 (US$1,150) for an egg donation cycle, and the amount of compensation increases each time they donate.
“Even if it is a low amount of money for all the process that it involves, it still appeals to a lot of women,” says Molas. However, under Spanish law, donors are considered to be motivated by altruism. “The fact that they are treated as donors, as volunteers, makes it very difficult to have a discussion about how much they should be paid,” she says.
Listen to the full interview on The Conversation Weekly podcast, and subscribe wherever you get your podcasts. You can also read an article Anna Molas wrote about her research, which is part of Women’s Health Matters – a series about the health and wellbeing of women and girls around the world.


GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
New York Declares Measles Disaster Emergency as Cases Surge
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
FDA Weighs Safety Standards for Psychedelic Therapies
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



